[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @doepke_michel Michel Doepke Michel Doepke posts on X about $vrna, $nvo, $mrk, $lly the most. They currently have XXXXX followers and 1687 posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1350720698591936515/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +39% - X Year XXXXXXXXX +290% ### Mentions: XX [#](/creator/twitter::1350720698591936515/posts_active)  - X Month XXX -XX% - X Months XXX +48% - X Year XXXXX +324% ### Followers: XXXXX [#](/creator/twitter::1350720698591936515/followers)  - X Week XXXXX +0.69% - X Month XXXXX +2.50% - X Months XXXXX +17% - X Year XXXXX +45% ### CreatorRank: XXXXXXX [#](/creator/twitter::1350720698591936515/influencer_rank)  ### Social Influence [#](/creator/twitter::1350720698591936515/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [currencies](/list/currencies) [countries](/list/countries) **Social topic influence** [$vrna](/topic/$vrna), [$nvo](/topic/$nvo), [$mrk](/topic/$mrk), [$lly](/topic/$lly), [$novob](/topic/$novob), [$pfe](/topic/$pfe), [$nvs](/topic/$nvs) #7, [acquisition](/topic/acquisition), [$jnj](/topic/$jnj) #9, [$smmt](/topic/$smmt) #6 **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [Novartis AG (NVS)](/topic/$nvs) [Johnson & Johnson (JNJ)](/topic/$jnj) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [AstraZeneca PLC (AZN)](/topic/$azn) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Synthetify (SNY)](/topic/$sny) [AbbVie Inc (ABBV)](/topic/$abbv) [Seagen Inc (SGEN)](/topic/$sgen) [Biogen Inc (BIIB)](/topic/$biib) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Vertex Protocol (VRTX)](/topic/$vrtx) [Immunogen Inc (IMGN)](/topic/$imgn) [Exelixis Inc (EXEL)](/topic/$exel) [Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Origin Protocol (OGN)](/topic/$ogn) [Qiagen NV (QGEN)](/topic/$qgen) [Incyte Corporation (INCY)](/topic/$incy) [Zimmer Biomet Holdings Inc (ZBH)](/topic/$zbh) [Bitcoin Incognito (XBI)](/topic/$xbi) [Insmed, Inc. (INSM)](/topic/$insm) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Sanofi (SNY)](/topic/sanofi) [SuperRare (RARE)](/topic/$rare) ### Top Social Posts [#](/creator/twitter::1350720698591936515/posts) --- Top posts by engagements in the last XX hours "$NBIX Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients at ENDO 2025. Should be supportive for a strong launch. Q2 earnings on Wednesday July 30"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944753998977802410) 2025-07-14 13:40:59 UTC 4834 followers, 1216 engagements "$MRK to acquire $VRNA - many people are just talking about the sales potential in #COPD which is a clear and huge blockbuster opportunity. But #VeronaPharma is running more interesting trials with ensifentrine. $VRTX $REGN"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942903503195615462) 2025-07-09 11:07:47 UTC 4833 followers, 2524 engagements "What a day for $CTMX - high volume and a strong gain. Interesting slide below - $IMMU (Trodelvy) $IMGN (Elahere) and $SGEN (Padcev) were acquired. $AZN / Daiichi = Enhertu billion $ deal. ADCs still a huge opportunity for big pharma. (Discl.: I own shares of $CTMX)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1927828532660461579) 2025-05-28 20:45:14 UTC 4831 followers, 4608 engagements "$EXEL #Ipsen receives positive CHMP opinion for Cabometyx in previously treated advanced neuroendocrine tumors"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1936007533325697434) 2025-06-20 10:25:39 UTC 4823 followers, XXX engagements "$MDGL up X% after really important patent news - protection until 2044. Reminds me of $ITCI when the patent overhang was lifted and then a short time later $JNJ acquired the company"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945462465019437397) 2025-07-16 12:36:11 UTC 4834 followers, 11.7K engagements "$CAPR Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy. $SRPT"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943628273541353834) 2025-07-11 11:07:45 UTC 4833 followers, 13.6K engagements "$NVO $NOVOB #NovoNordisk still XX% below ATH. Waiting for new data at #ADA25 #Amycretin development path news and NN130 data. $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1933085389222498739) 2025-06-12 08:54:06 UTC 4833 followers, 4311 engagements "$LLY FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease. $BIIB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942928876176646426) 2025-07-09 12:48:36 UTC 4824 followers, XXX engagements "#Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945738681211404594) 2025-07-17 06:53:46 UTC 4834 followers, XXX engagements "Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299 An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront $BNTX $SMMT $PFE"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945105697462513908) 2025-07-15 12:58:31 UTC 4833 followers, 2391 engagements "Sironax Grants $NVS Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets - Sironax to receive up to $XXX million in upfront and near-term payments"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942918484586840112) 2025-07-09 12:07:19 UTC 4833 followers, XXX engagements "$TLX Gozellix Receives Permanent HCPCS Code. $LNTH"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942863963210846225) 2025-07-09 08:30:40 UTC 4833 followers, XXX engagements "$JSPR had $48.8M cash at the end of March. Mcap now below"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942193798391455937) 2025-07-07 12:07:40 UTC 4830 followers, 2131 engagements "Official PR: $MRK to acquire $VRNA Expanding its Portfolio to Include Ohtuvayre (ensifentrine) a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade. $XXX per share"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942894469679849734) 2025-07-09 10:31:53 UTC 4829 followers, 5868 engagements "$SMMT key message after the latest Ivonescimab data set. The crucial point remains the validity of Chinese study data imho. #Akeso $BNTX $PFE $MRK"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1928405118678147127) 2025-05-30 10:56:22 UTC 4833 followers, 6446 engagements "$NVO $NOVOB New Wegovy dose submitted to European Medicines Agency for approval with X in X trial participants achieving XX% or more weight loss. $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942573241413099929) 2025-07-08 13:15:26 UTC 4829 followers, 3110 engagements "$OGN axes 'biggest potential opportunity' after flunking phase X trial"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1940394425143939524) 2025-07-02 12:57:36 UTC 4833 followers, XXX engagements "$NVS got access to #Pluvicto with the acquisition of #Endocyte back in 2018. This year #Novartis will generate approximately the purchase price with Pluvicto sales alone. Probably one of the best takeovers by Novartis in recent years which has quickly paid off"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945723900895117732) 2025-07-17 05:55:02 UTC 4834 followers, XXX engagements "More and more analysts realize the sales potential for #Attruby and the late stage pipeline potential of $BBIO. Today Jefferies initiated the shares of the rare disease company with a "Buy" and PT $XX. As I wrote in January: strong launch can lead to a "massive revaluation""  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944706966602846651) 2025-07-14 10:34:06 UTC 4824 followers, 2460 engagements "$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944714969359978990) 2025-07-14 11:05:54 UTC 4833 followers, XXX engagements "$QIA $QGEN and $INCY Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1934163782772859339) 2025-06-15 08:19:15 UTC 4816 followers, 1089 engagements "$VRNA buyout today. $BBIO also on my M&A list - #Attruby will be also a clear blockbuster"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943031402401759604) 2025-07-09 19:36:00 UTC 4821 followers, 3320 engagements "$ZBH Announces Definitive Agreement to Acquire $MGRM Expanding Robotics Suite with Autonomous Solutions"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944721699712233973) 2025-07-14 11:32:39 UTC 4827 followers, XXX engagements "$XBI It is time for a move higher in biotech says Mizuho's Jared Holz $GILD $INSM $BMRN $BBIO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942589665611243647) 2025-07-08 14:20:42 UTC 4834 followers, 1712 engagements "$COGT positive top-line results from the registration-directed Part X of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). NDA submission to FDA expected by end of 2025. $BPMC $SNY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942180954354688318) 2025-07-07 11:16:38 UTC 4833 followers, 1928 engagements "$NVO $NOVOB #NovoNordisk - #Amycretin results from a phase 1b/2a randomised controlled study. "High proportion of discontinuations". $LLY $VKTX"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943632096611737889) 2025-07-11 11:22:57 UTC 4833 followers, 13.3K engagements "#Radiopharma space never sleeps: Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy. $TLX"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942921234661982486) 2025-07-09 12:18:14 UTC 4822 followers, XXX engagements "BINGO $RHHBY enters into an exclusive collaboration & licensing agreement with $ZEAL to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity. $1.65B upfront #Amylin $GUBRA $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1899702655242420464) 2025-03-12 06:03:02 UTC 4833 followers, 34.4K engagements "$LXEO Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia. $BIIB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942177269046239522) 2025-07-07 11:01:59 UTC 4824 followers, XXX engagements "$ARGX upgraded from "Hold" to "Buy" at Deutsche Bank - PT from XXX to 550"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942468916099362850) 2025-07-08 06:20:53 UTC 4834 followers, XXX engagements "$BAYN #Bayer FDA Approves Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of 40%"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944650184924733534) 2025-07-14 06:48:28 UTC 4827 followers, 1662 engagements "$MRK Nears $XX Billion Deal for Drugmaker $VRNA FT Says. @business: Wrong picture it is the logo of the German based @merck_de"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942819099542970633) 2025-07-09 05:32:23 UTC 4829 followers, 1439 engagements "$BPMC leader in the SM niche acquired by $SNY $VRNA with novel treatment for COPD acquired by $MRK In my opinion the next logical takeover candidate among the commercial stage biotechs is $MDGL. First mover in the field of NASH. Blockbuster in the making. Could be in the same price range. $PFE $BMY $NVS"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942896827302326622) 2025-07-09 10:41:15 UTC 4834 followers, 6460 engagements "$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944729228684976503) 2025-07-14 12:02:34 UTC 4834 followers, 4569 engagements "#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945352745789075532) 2025-07-16 05:20:12 UTC 4834 followers, XXX engagements "$GILD Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942917276392452366) 2025-07-09 12:02:31 UTC 4834 followers, 1082 engagements "$MDGL Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945453848472043757) 2025-07-16 12:01:56 UTC 4834 followers, 8588 engagements "$JNJ #Stelara erosion. #Biosimilars are taking market share"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945440385653694859) 2025-07-16 11:08:27 UTC 4833 followers, 1033 engagements "Finally $MCRB got some attention shares doubled in about three weeks. #Makary effect No company news out there. Own a tiny position"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945113294928290119) 2025-07-15 13:28:42 UTC 4833 followers, XXX engagements "$VKTX moving higher after $VRNA buyout touching $XX. Disclaimer below. 👇🥳"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942939869816172667) 2025-07-09 13:32:17 UTC 4824 followers, 3781 engagements "$MTSR up XX% in five days. Best performing #obesity play in the past few weeks. Something brewing $LLY $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945117923896365381) 2025-07-15 13:47:06 UTC 4833 followers, 5426 engagements "$SNY SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945352428221497799) 2025-07-16 05:18:56 UTC 4824 followers, XXX engagements "$RARE Health Canada Extends the Approval of Evkeeza (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944729443877920817) 2025-07-14 12:03:25 UTC 4827 followers, 1457 engagements "$PROK wow. Shares still on fire after announced statistically and clinically significant Topline Results for the Phase X REGEN-007 Trial with Rilparencel in Patients with CKD and Diabetes. Palihapitiya backed SPAC from 2022"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942915506014392563) 2025-07-09 11:55:28 UTC 4833 followers, 6104 engagements "$BCYC Baker Bros not satisfied: Felix J. Baker Ph.D. to become chairman of Board of Directors. Pushing for M&A deal $SGEN"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1905336553359942008) 2025-03-27 19:10:08 UTC 4824 followers, 5325 engagements "$JSPR down 40%: Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria. $BPMC $CLDX (I own shares of $CLDX)"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942188000076599661) 2025-07-07 11:44:37 UTC 4830 followers, 5677 engagements "Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA (ustekinumab-hmny) Injection a biosimilar referencing STELARA (ustekinumab) Injection. $JNJ $FYB"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1927244185360289978) 2025-05-27 06:03:14 UTC 4824 followers, XXX engagements "$VITR #Vitrolife - Inside the IVF deliberations at the White House as key report nears. Via @seattletimes"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1924352742673305798) 2025-05-19 06:33:41 UTC 4821 followers, XXX engagements "$ZEAL announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide. $GUBRA $NVO $VKTX $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1935361269835399225) 2025-06-18 15:37:38 UTC 4833 followers, 3848 engagements "$RDC #Redcare Pharmacy confirms guidance for all elements after strong Q2 performance with total sales growing XXXX% - no PW. CFO: "We expect our Q2 EBITDA margin to be above X% with further improvement in the second half of the year.""  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1940641253219287458) 2025-07-03 05:18:24 UTC 4829 followers, 2196 engagements "$CANTA #Cantargia +195% - announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical. $33M upfront + up to $580M milestones + earn-out payments from global product sales"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945120204935098798) 2025-07-15 13:56:10 UTC 4834 followers, 1641 engagements "$NVS receives approval for first malaria medicine for newborn babies and young infants"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942452833720115505) 2025-07-08 05:16:59 UTC 4816 followers, XXX engagements "$CAI Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection Minimal Residual Disease and Therapy Selection. $GRAL $PSNL"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942532700872818961) 2025-07-08 10:34:21 UTC 4834 followers, 1231 engagements "$NVO $NOVOB #NovoNordisk CagriSema XXX mg / XXX mg demonstrated XXXX% mean weight reduction in adults with overweight or obesity in REDEFINE X published in New England Journal of Medicine. $LLY"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1936772827966836934) 2025-06-22 13:06:40 UTC 4832 followers, 7817 engagements "Barclays initiated $ZEAL with a "Buy" and DKK XXX PT. $GUBRA $NVO"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942452210987569187) 2025-07-08 05:14:30 UTC 4827 followers, XXX engagements "$KIT.OL #Kitron hit a new ATH today higher defense spending in Europe (for example in France; one customer of Kitron is #Thales) continues to boost the share price. Shares up XX% since post below. 👇👇👇"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944725091259965628) 2025-07-14 11:46:07 UTC 4828 followers, 1109 engagements "India's Glenmark Pharma soars XX% to record high on $ABBV cancer treatment licensing deal"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1943594639115632744) 2025-07-11 08:54:06 UTC 4823 followers, XXX engagements "$MRK to acquire $VRNA for $10B FT reports - would be XXX dollar per share = almost XXX% in less than a year. 🥳👇Would be the biggest acquisition of Merck & Co since Prometheus in June 2023"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942824695406952767) 2025-07-09 05:54:37 UTC 4829 followers, 16.6K engagements "$ARWR Initiates Phase X YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia"  [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1942547419842896302) 2025-07-08 11:32:50 UTC 4833 followers, 1663 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke posts on X about $vrna, $nvo, $mrk, $lly the most. They currently have XXXXX followers and 1687 posts still getting attention that total XXXXXX engagements in the last XX hours.
Social category influence stocks finance cryptocurrencies currencies countries
Social topic influence $vrna, $nvo, $mrk, $lly, $novob, $pfe, $nvs #7, acquisition, $jnj #9, $smmt #6
Top assets mentioned Novo-Nordisk (NVO) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Novartis AG (NVS) Johnson & Johnson (JNJ) Summit Therapeutics Inc. Common Stock (SMMT) Blueprint Medicines Corporation (BPMC) Viking Therapeutics, Inc (VKTX) AstraZeneca PLC (AZN) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) BridgeBio Pharma, Inc. Common Stock (BBIO) Gilead Sciences, Inc. (GILD) Synthetify (SNY) AbbVie Inc (ABBV) Seagen Inc (SGEN) Biogen Inc (BIIB) Celldex Therapeutics, Inc (CLDX) Alnylam Pharmaceuticals, Inc. (ALNY) Bristol-Myers Squibb Co (BMY) Metsera, Inc. Common Stock (MTSR) Neurocrine Biosciences, Inc. (NBIX) Regeneron Pharmaceuticals Inc (REGN) Vertex Protocol (VRTX) Immunogen Inc (IMGN) Exelixis Inc (EXEL) Intra-Cellular Therapies Inc. (ITCI) Sarepta Therapeutics, Inc. (SRPT) Lantheus Holdings, Inc (LNTH) Origin Protocol (OGN) Qiagen NV (QGEN) Incyte Corporation (INCY) Zimmer Biomet Holdings Inc (ZBH) Bitcoin Incognito (XBI) Insmed, Inc. (INSM) BioMarin Pharmaceutical, Inc. (BMRN) Corcept Therapeutics Inc. (CORT) Sanofi (SNY) SuperRare (RARE)
Top posts by engagements in the last XX hours
"$NBIX Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients at ENDO 2025. Should be supportive for a strong launch. Q2 earnings on Wednesday July 30" @doepke_michel on X 2025-07-14 13:40:59 UTC 4834 followers, 1216 engagements
"$MRK to acquire $VRNA - many people are just talking about the sales potential in #COPD which is a clear and huge blockbuster opportunity. But #VeronaPharma is running more interesting trials with ensifentrine. $VRTX $REGN" @doepke_michel on X 2025-07-09 11:07:47 UTC 4833 followers, 2524 engagements
"What a day for $CTMX - high volume and a strong gain. Interesting slide below - $IMMU (Trodelvy) $IMGN (Elahere) and $SGEN (Padcev) were acquired. $AZN / Daiichi = Enhertu billion $ deal. ADCs still a huge opportunity for big pharma. (Discl.: I own shares of $CTMX)" @doepke_michel on X 2025-05-28 20:45:14 UTC 4831 followers, 4608 engagements
"$EXEL #Ipsen receives positive CHMP opinion for Cabometyx in previously treated advanced neuroendocrine tumors" @doepke_michel on X 2025-06-20 10:25:39 UTC 4823 followers, XXX engagements
"$MDGL up X% after really important patent news - protection until 2044. Reminds me of $ITCI when the patent overhang was lifted and then a short time later $JNJ acquired the company" @doepke_michel on X 2025-07-16 12:36:11 UTC 4834 followers, 11.7K engagements
"$CAPR Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy. $SRPT" @doepke_michel on X 2025-07-11 11:07:45 UTC 4833 followers, 13.6K engagements
"$NVO $NOVOB #NovoNordisk still XX% below ATH. Waiting for new data at #ADA25 #Amycretin development path news and NN130 data. $LLY" @doepke_michel on X 2025-06-12 08:54:06 UTC 4833 followers, 4311 engagements
"$LLY FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease. $BIIB" @doepke_michel on X 2025-07-09 12:48:36 UTC 4824 followers, XXX engagements
"#Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss" @doepke_michel on X 2025-07-17 06:53:46 UTC 4834 followers, XXX engagements
"Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299 An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront $BNTX $SMMT $PFE" @doepke_michel on X 2025-07-15 12:58:31 UTC 4833 followers, 2391 engagements
"Sironax Grants $NVS Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets - Sironax to receive up to $XXX million in upfront and near-term payments" @doepke_michel on X 2025-07-09 12:07:19 UTC 4833 followers, XXX engagements
"$TLX Gozellix Receives Permanent HCPCS Code. $LNTH" @doepke_michel on X 2025-07-09 08:30:40 UTC 4833 followers, XXX engagements
"$JSPR had $48.8M cash at the end of March. Mcap now below" @doepke_michel on X 2025-07-07 12:07:40 UTC 4830 followers, 2131 engagements
"Official PR: $MRK to acquire $VRNA Expanding its Portfolio to Include Ohtuvayre (ensifentrine) a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade. $XXX per share" @doepke_michel on X 2025-07-09 10:31:53 UTC 4829 followers, 5868 engagements
"$SMMT key message after the latest Ivonescimab data set. The crucial point remains the validity of Chinese study data imho. #Akeso $BNTX $PFE $MRK" @doepke_michel on X 2025-05-30 10:56:22 UTC 4833 followers, 6446 engagements
"$NVO $NOVOB New Wegovy dose submitted to European Medicines Agency for approval with X in X trial participants achieving XX% or more weight loss. $LLY" @doepke_michel on X 2025-07-08 13:15:26 UTC 4829 followers, 3110 engagements
"$OGN axes 'biggest potential opportunity' after flunking phase X trial" @doepke_michel on X 2025-07-02 12:57:36 UTC 4833 followers, XXX engagements
"$NVS got access to #Pluvicto with the acquisition of #Endocyte back in 2018. This year #Novartis will generate approximately the purchase price with Pluvicto sales alone. Probably one of the best takeovers by Novartis in recent years which has quickly paid off" @doepke_michel on X 2025-07-17 05:55:02 UTC 4834 followers, XXX engagements
"More and more analysts realize the sales potential for #Attruby and the late stage pipeline potential of $BBIO. Today Jefferies initiated the shares of the rare disease company with a "Buy" and PT $XX. As I wrote in January: strong launch can lead to a "massive revaluation"" @doepke_michel on X 2025-07-14 10:34:06 UTC 4824 followers, 2460 engagements
"$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off" @doepke_michel on X 2025-07-14 11:05:54 UTC 4833 followers, XXX engagements
"$QIA $QGEN and $INCY Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)" @doepke_michel on X 2025-06-15 08:19:15 UTC 4816 followers, 1089 engagements
"$VRNA buyout today. $BBIO also on my M&A list - #Attruby will be also a clear blockbuster" @doepke_michel on X 2025-07-09 19:36:00 UTC 4821 followers, 3320 engagements
"$ZBH Announces Definitive Agreement to Acquire $MGRM Expanding Robotics Suite with Autonomous Solutions" @doepke_michel on X 2025-07-14 11:32:39 UTC 4827 followers, XXX engagements
"$XBI It is time for a move higher in biotech says Mizuho's Jared Holz $GILD $INSM $BMRN $BBIO" @doepke_michel on X 2025-07-08 14:20:42 UTC 4834 followers, 1712 engagements
"$COGT positive top-line results from the registration-directed Part X of the SUMMIT clinical trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). NDA submission to FDA expected by end of 2025. $BPMC $SNY" @doepke_michel on X 2025-07-07 11:16:38 UTC 4833 followers, 1928 engagements
"$NVO $NOVOB #NovoNordisk - #Amycretin results from a phase 1b/2a randomised controlled study. "High proportion of discontinuations". $LLY $VKTX" @doepke_michel on X 2025-07-11 11:22:57 UTC 4833 followers, 13.3K engagements
"#Radiopharma space never sleeps: Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy. $TLX" @doepke_michel on X 2025-07-09 12:18:14 UTC 4822 followers, XXX engagements
"BINGO $RHHBY enters into an exclusive collaboration & licensing agreement with $ZEAL to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity. $1.65B upfront #Amylin $GUBRA $NVO" @doepke_michel on X 2025-03-12 06:03:02 UTC 4833 followers, 34.4K engagements
"$LXEO Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia. $BIIB" @doepke_michel on X 2025-07-07 11:01:59 UTC 4824 followers, XXX engagements
"$ARGX upgraded from "Hold" to "Buy" at Deutsche Bank - PT from XXX to 550" @doepke_michel on X 2025-07-08 06:20:53 UTC 4834 followers, XXX engagements
"$BAYN #Bayer FDA Approves Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of 40%" @doepke_michel on X 2025-07-14 06:48:28 UTC 4827 followers, 1662 engagements
"$MRK Nears $XX Billion Deal for Drugmaker $VRNA FT Says. @business: Wrong picture it is the logo of the German based @merck_de" @doepke_michel on X 2025-07-09 05:32:23 UTC 4829 followers, 1439 engagements
"$BPMC leader in the SM niche acquired by $SNY $VRNA with novel treatment for COPD acquired by $MRK In my opinion the next logical takeover candidate among the commercial stage biotechs is $MDGL. First mover in the field of NASH. Blockbuster in the making. Could be in the same price range. $PFE $BMY $NVS" @doepke_michel on X 2025-07-09 10:41:15 UTC 4834 followers, 6460 engagements
"$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV" @doepke_michel on X 2025-07-14 12:02:34 UTC 4834 followers, 4569 engagements
"#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT" @doepke_michel on X 2025-07-16 05:20:12 UTC 4834 followers, XXX engagements
"$GILD Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries" @doepke_michel on X 2025-07-09 12:02:31 UTC 4834 followers, 1082 engagements
"$MDGL Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom)" @doepke_michel on X 2025-07-16 12:01:56 UTC 4834 followers, 8588 engagements
"$JNJ #Stelara erosion. #Biosimilars are taking market share" @doepke_michel on X 2025-07-16 11:08:27 UTC 4833 followers, 1033 engagements
"Finally $MCRB got some attention shares doubled in about three weeks. #Makary effect No company news out there. Own a tiny position" @doepke_michel on X 2025-07-15 13:28:42 UTC 4833 followers, XXX engagements
"$VKTX moving higher after $VRNA buyout touching $XX. Disclaimer below. 👇🥳" @doepke_michel on X 2025-07-09 13:32:17 UTC 4824 followers, 3781 engagements
"$MTSR up XX% in five days. Best performing #obesity play in the past few weeks. Something brewing $LLY $NVO" @doepke_michel on X 2025-07-15 13:47:06 UTC 4833 followers, 5426 engagements
"$SNY SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration" @doepke_michel on X 2025-07-16 05:18:56 UTC 4824 followers, XXX engagements
"$RARE Health Canada Extends the Approval of Evkeeza (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)" @doepke_michel on X 2025-07-14 12:03:25 UTC 4827 followers, 1457 engagements
"$PROK wow. Shares still on fire after announced statistically and clinically significant Topline Results for the Phase X REGEN-007 Trial with Rilparencel in Patients with CKD and Diabetes. Palihapitiya backed SPAC from 2022" @doepke_michel on X 2025-07-09 11:55:28 UTC 4833 followers, 6104 engagements
"$BCYC Baker Bros not satisfied: Felix J. Baker Ph.D. to become chairman of Board of Directors. Pushing for M&A deal $SGEN" @doepke_michel on X 2025-03-27 19:10:08 UTC 4824 followers, 5325 engagements
"$JSPR down 40%: Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria. $BPMC $CLDX (I own shares of $CLDX)" @doepke_michel on X 2025-07-07 11:44:37 UTC 4830 followers, 5677 engagements
"Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA (ustekinumab-hmny) Injection a biosimilar referencing STELARA (ustekinumab) Injection. $JNJ $FYB" @doepke_michel on X 2025-05-27 06:03:14 UTC 4824 followers, XXX engagements
"$VITR #Vitrolife - Inside the IVF deliberations at the White House as key report nears. Via @seattletimes" @doepke_michel on X 2025-05-19 06:33:41 UTC 4821 followers, XXX engagements
"$ZEAL announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide. $GUBRA $NVO $VKTX $LLY" @doepke_michel on X 2025-06-18 15:37:38 UTC 4833 followers, 3848 engagements
"$RDC #Redcare Pharmacy confirms guidance for all elements after strong Q2 performance with total sales growing XXXX% - no PW. CFO: "We expect our Q2 EBITDA margin to be above X% with further improvement in the second half of the year."" @doepke_michel on X 2025-07-03 05:18:24 UTC 4829 followers, 2196 engagements
"$CANTA #Cantargia +195% - announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical. $33M upfront + up to $580M milestones + earn-out payments from global product sales" @doepke_michel on X 2025-07-15 13:56:10 UTC 4834 followers, 1641 engagements
"$NVS receives approval for first malaria medicine for newborn babies and young infants" @doepke_michel on X 2025-07-08 05:16:59 UTC 4816 followers, XXX engagements
"$CAI Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection Minimal Residual Disease and Therapy Selection. $GRAL $PSNL" @doepke_michel on X 2025-07-08 10:34:21 UTC 4834 followers, 1231 engagements
"$NVO $NOVOB #NovoNordisk CagriSema XXX mg / XXX mg demonstrated XXXX% mean weight reduction in adults with overweight or obesity in REDEFINE X published in New England Journal of Medicine. $LLY" @doepke_michel on X 2025-06-22 13:06:40 UTC 4832 followers, 7817 engagements
"Barclays initiated $ZEAL with a "Buy" and DKK XXX PT. $GUBRA $NVO" @doepke_michel on X 2025-07-08 05:14:30 UTC 4827 followers, XXX engagements
"$KIT.OL #Kitron hit a new ATH today higher defense spending in Europe (for example in France; one customer of Kitron is #Thales) continues to boost the share price. Shares up XX% since post below. 👇👇👇" @doepke_michel on X 2025-07-14 11:46:07 UTC 4828 followers, 1109 engagements
"India's Glenmark Pharma soars XX% to record high on $ABBV cancer treatment licensing deal" @doepke_michel on X 2025-07-11 08:54:06 UTC 4823 followers, XXX engagements
"$MRK to acquire $VRNA for $10B FT reports - would be XXX dollar per share = almost XXX% in less than a year. 🥳👇Would be the biggest acquisition of Merck & Co since Prometheus in June 2023" @doepke_michel on X 2025-07-09 05:54:37 UTC 4829 followers, 16.6K engagements
"$ARWR Initiates Phase X YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia" @doepke_michel on X 2025-07-08 11:32:50 UTC 4833 followers, 1663 engagements
/creator/x::doepke_michel